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DEAR EDITOR, Systemic lupus erythematosus (SLE) is a common prototypic 
autoimmune disease with substantial genetic predispositions. It is more prevalent in 
Asians than in Caucasians. Genome wide association studies (GWAS) have 
discovered more than 80 genetic loci for the risk of SLE1, which improve the 
understanding of SLE etiology and provide potential therapeutic targets. However, 
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fully explain SLE heritability, suggesting more genetic variants are yet to be 
discovered.                                                        
To detect novel susceptibility loci for SLE, we conducted a two-stage GWAS in a Han 
Chinese population. All patients met the revised American College of Rheumatology 
SLE classification criteria2. The age- matched controls were recruited without SLE, 
family history of SLE or any other autoimmune disea es. Each participant provided 
written informed consent. The study was approved by the Institutional Review Board 
of Anhui Medical University, China, and was conducted according to the Declaration 
of Helsinki. 
In the discovery stage, we performed strict quality control on variants and samples in 
the SLE GWAS data set, which have been described before2. After quality control, the 
genotype data of 493,955 autosomal SNPs in 1,047 SLE cases and 1,205 controls 
were imputed using IMPUTE 2 together with the 1000 Genomes Project reference 
data (phase 1 integrated set, March 2012, build 37). The SNPs with imputation INFO 
scores of >0.9 were included in further analyses. A logistic regression model (additive 
model) was used for single-variant association analysis with gender as a covariate.  
In the replication stage, we genotyped 82 top SNPs in an independent cohort of 3,509 
cases and 8,246 controls using the Sequenom MassARRAY system. The SNPs were 
chosen if they satisfied several criteria: (1) beyond 500kb from any SLE locus; (2) not 
within the major histocompatibility complex region; (3) with P < 5.00×10-4 in the 
discovery stage; (4) Hardy-Weinberg Equilibrium P ≥ 10-4
We aggregated the association evidence through a meta-analysis using METAL and 
evaluated the heterogeneity between the two stages via the I
 in both controls and 
cases; (5) Minor allele frequency > 1%; (6) within known susceptibility genes/loci for 
autoimmune disorders. We tested their association for the risk of SLE in Plink 1.07 
using logistic regression (additive model) with gender as a covariate. 
2 and Q statistics. There 
were 17 SNPs that met the threshold of genome-wide significance but 14 of them 
failed a Hardy-Weinberg Equilibrium test at P ＜ 10-4 or with I2 ＞ 30%. We 
identified three novel loci associated with disease: KIT (rs2855772_C, Odds ratio (OR) 
= 1.40, P meta = 1.21×10
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and TRAPPC11 (rs10018951_T, OR = 1.31, P meta = 1.18×10
-14) (Table 1). Rs2855772 
is resided in an intron of KIT which is a tyrosine kinase receptor and plays a key role 
in cell differentiation and survival of immune cells. The KIT ligand-binding can 
promote the activation of STAT family members in JAK/STAT signaling which is 
critical in SLE3. Moreover, the soluble KIT (sKIT) level is significantly lower in SLE 
patients and is correlated with titer of anti-DNA antibody and the SLE activity index 
(SLEDAI) score. It is also negatively affected by high doses of corticosteroid for SLE 
therapy4. Rs13116227 locates ~2.2 kb 5’-upstream of GPR78 ,which is a member of 
G Protein–Coupled Receptor and coupled to stimulatory (Gs) protein resulting in 
increased cyclic AMP (cAMP) which then inhibits NF-κB activation5. Rs10018951 
locates in an intron of the TRAPPC11 gene and encodes the enhancer regulatory 
function for TRAPPC11 in CD14+ monocytes and skin6. TRAPPC11 encodes a 
component of the transport protein particle (TRAPP) complex. Depletion of 
TRAPPC11 will cause a stressed unfolded protein response (UPR). Persistent UPR 
results in endoplasmic reticulum stress, which in turn is associated with cell 
dysfunction and apoptosis7. Apoptosis-related genes have been found to have more 
than twofold higher expression levels in SLE patients with active disease compared to 
those with inactive disease8.  
We conducted Real-Time PCR (RT-PCR) and expression quantitative trait loci（eQTL）
to determine gene expression differences and regulatory effect of SNPs, respectively. 
We also analyzed the correlation between genes’ mRNA expression levels and clinical 
parameters of SLE. Unfortunately, the results were statistically insignificant after 
correcting for multiple testing. 
In conclusion, we identified three novel susceptibility regions at KIT, GPR78 and 
TRAPPC11 for SLE. These discoveries provide new insights into the genetic and 
biological basis of SLE. 
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Table 1. Three novel genome-wide significant SLE SNPs that was identified in this study. 
SNP Chr  
Positon 
（hg19） Gene* Allele**  
GWAS Replication Meta 
  1,047 cases, 1,205 controls     3,509 cases, 8,246 control 4,556cases, 9451controls 
MAF  OR 
(95%CI)  
P***  MAF  OR 
(95%CI)  
P***  P OR hew P**** Imeta 
2 
          Case Control    Case Control            
rs2855772 4 55548475 KIT C/T 0.1433 0.1041 1.44(1.20-1.72) 6.44E-05 0.1312 0.09772 1.39(1.27-1.53) 2.95E-12 0.04074 1.40  .21E-15 0 
rs13116227 4 8558266    2.2kb 5' of GPR78 T/C 0.1299 0.09253 1.46(1.21-1.77) 6.37E-05 0.1211 0.09561 1.30(1.18-1.44) 5.57E-08 0.3896 1.34 3.05E-11 13.71% 
rs10018951 4 184609373 TRAPPC11 T/C 0.2101 0.1622 1.37(1.81-1.60) 3.60E-05 0.193 0.1555 1.30(1.20-1.41) 4.86E-11 0.5372 1.31 1.18E-14 0 
*Annotated by Haploreg v4.1 (http://archive.broadinstitute.org/mammals/haploreg/haploreg.php） 
**Minor allele/Major allele.  
***Association statistic adjusted for gender. 
****Asso ciation statistic adjusted for gender and study. 
  
The details of other SNPs selected for the replication study can be obtained by application to the corresponding author.  
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